Literature DB >> 6788267

Dangers of amiodarone and anticoagulant treatment.

M J Serlin, R G Sibeon, G J Green.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6788267      PMCID： PMC1506001          DOI： 10.1136/bmj.283.6283.58-b

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  1 in total

1.  Interaction between warfarin sodium and amiodarone.

Authors:  U Martinowitz; J Rabinovich; D Goldfarb; A Many; H Bank
Journal:  N Engl J Med       Date:  1981-03-12       Impact factor: 91.245
  1 in total
  11 in total

Review 1.  Therapeutic drug monitoring: antiarrhythmic drugs.

Authors:  T J Campbell; K M Williams
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

2.  In vitro amiodarone protein binding and its interaction with warfarin.

Authors:  P Neyroz; M Bonati
Journal:  Experientia       Date:  1985-03-15

3.  Renal elimination of amiodarone and its desethyl metabolite.

Authors:  L Harris; C R Hind; W J McKenna; C Savage; S J Krikler; G C Storey; D W Holt
Journal:  Postgrad Med J       Date:  1983-07       Impact factor: 2.401

Review 4.  Drug interactions with warfarin.

Authors:  M J Serlin; A M Breckenridge
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

5.  Influence of amiodarone on antipyrine pharmacokinetics in three patients with ventricular tachycardia.

Authors:  C Staiger; R Jauernig; J de Vries; E Weber
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

6.  Prospective study of the potentiation of acenocoumarol by amiodarone.

Authors:  C Richard; B Riou; A Berdeaux; C Fournier; D Khayat; A Rimailho; J F Giudicelli; P Auzépy
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 7.  Pharmacokinetic drug interactions with amiodarone.

Authors:  L J Lesko
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of amiodarone.

Authors:  R Latini; G Tognoni; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 9.  Clinical pharmacokinetics of the newer antiarrhythmic agents.

Authors:  A M Gillis; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

10.  Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination.

Authors:  S Almog; N Shafran; H Halkin; P Weiss; Z Farfel; U Martinowitz; H Bank
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.